RxDoctor Payments DataLook up a doctor →

SPIRIVA RESPIMAT: payments to doctors

Payments that named SPIRIVA RESPIMAT as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3.6M
Providers
42,343
Transactions
208,335
Average per transaction
$17

The per-transaction average — $17 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 42,343 providers the average total is $84, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Boehringer Ingelheim$3,503,91197.9%
Boehringer Ingelheim International GmbH$73,9722.1%
← All drugs & devices